title: Dose rate effect of 125I irradiation on normal rabbit eyes and experimental choroidal melanoma.
abstract: The dose rate effect of radiation by 125I plaque on choroidal melanoma and normal intraocular tissue was studied. In the first part of the experiment, high activity plaques (HAP) and low activity plaques (LAP) were implanted on rabbit eyes with experimental Greene choroidal melanoma to deliver a total dose of 10,000 cGy to the tumor apex. The mean dose rate calculated at 0.5 mm from the inner sclera in eight eyes with high activity plaques was 3341.5 cGy hr-1 (1 cGy = 1 rad) while that in ten eyes with low activity plaques was 239.9 cGy hr-1. For tumors less than 1.0 mm in height, both groups showed complete tumor regression at the tumor implantation site after plaque treatment. For tumors more than 1.0 mm in height, two out of two eyes in the low activity plaque group and one of four eyes in the high activity plaque group failed to show complete tumor regression. Both LAP and HAP were effective in eradicating tumors, but logistic regression analysis demonstrates that HAP was more effective than LAP when adjustment was made for initial tumor height (P = 0.032). Nine tumor control eyes without 125I plaque implantation demonstrated marked tumor growth within 3 weeks. In the second part of the experiment, 125I plaques were implanted on the sclera of 12 normal rabbits' eyes. Six received high dose rate plaque treatment, while the other six received low dose rate plaque treatment. Clinical and histologic examinations demonstrated more damaging effects to the normal chorioretinal tissues at the plaque implantation site in the high dose rate plaque group at 24 weeks of follow-up. These results suggest that high dose rate plaques are more effective than low dose rate plaques when tumor height is statistically controlled. However, high dose rate delivery increases the damaging effects on normal intraocular tissue.
authors.affiliation: Department of Ophthalmology, Bascom Palmer Eye Institute, Miami, FL.
authors.forename: C M
authors.initials: CM
authors.lastname: Yang
authors.forename: K R
authors.initials: KR
authors.lastname: Olsen
authors.forename: J G
authors.initials: JG
authors.lastname: Schwade
authors.forename: P V
authors.initials: PV
authors.lastname: Houdek
authors.forename: A M
authors.initials: AM
authors.lastname: Markoe
authors.forename: V
authors.initials: V
authors.lastname: Pisciotta
authors.forename: X
authors.initials: X
authors.lastname: Wu
mesh_terms: D000818:Animals; D001918:Brachytherapy; D002829:Choroid / Q000098:blood supply; D002830:Choroid Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D004307:Dose-Response Relationship, Radiation; D005123:Eye / Q000528:radiation effects*; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008546:Melanoma, Experimental / Q000473:pathology / Q000532:radiotherapy*; D011817:Rabbits; D011879:Radiotherapy Dosage
chemical_list: D007457:Iodine Radioisotopes